FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036005157> ?p ?o ?g. }

• W3036005157 endingPage "4347" @default.
• W3036005157 startingPage "4347" @default.
• W3036005157 abstract "Tacrolimus has been used to induce remission in patients with steroid-refractory ulcerative colitis. It poses a problem of large individual differences in dosage necessary to attain target blood concentration and, often, this leads to drug inefficacy. We examined the difference in mRNA expression levels of ATP binding cassette transporter B1 (ABCB1) between inflamed and non-inflamed tissues, and the influence of CYP3A5 genotype on tacrolimus therapy. The mRNA expression of CYP3A4 in colonic mucosa and that of cytochrome p450 3A5 (CYP3A5) and ABCB1 in inflamed and non-inflamed areas were examined in 14 subjects. The mRNA expression levels of CYP3A5 were higher than that of CYP3A4. The mRNA expression of ABCB1 was lower in the inflamed than in the non-inflamed mucosa, despite that of CYP3A5 mRNA level being not significantly changed. Hence, the deterioration of the disease is related to the reduction of the barrier in the inflamed mucosa. The relationship between CYP3A5 genotype and blood concentration, dose, and concentration/dose (C/D) ratio of tacrolimus in 15 subjects was studied. The tacrolimus dose to maintain equivalent blood concentrations was lower in CYP3A5*3/*3 than in CYP3A5*1 carriers, and the C/D ratio was significantly higher in the latter. Thus, CYP3A5 polymorphism information played a role in determining the initial dose of tacrolimus. Furthermore, since the effect of tacrolimus appears earlier in CYP3A5*3/*3 than in CYP3A5*1/*1 and *1/*3, it seems necessary to change the evaluation time of therapeutic effect by CYP3A5 genotype. Additionally, the relationship between CYP3A5 genotype and C/D ratio of tacrolimus in colonic mucosa was investigated in 10 subjects. Tacrolimus concentration in the mucosa was two-fold higher in CYP3A5*3/*3 than in CYP3A5*1 carriers, although no significant difference in tacrolimus-blood levels was observed. Therefore, the local concentration of tacrolimus affected by CYP3A5 polymorphism might be related to its therapeutic effect." @default.
• W3036005157 created "2020-06-25" @default.
• W3036005157 creator A5002391399 @default.
• W3036005157 creator A5004410085 @default.
• W3036005157 creator A5051804635 @default.
• W3036005157 creator A5067289515 @default.
• W3036005157 creator A5070223885 @default.
• W3036005157 date "2020-06-18" @default.
• W3036005157 modified "2023-10-09" @default.
• W3036005157 title "CYP3A5 Genotype as a Potential Pharmacodynamic Biomarker for Tacrolimus Therapy in Ulcerative Colitis in Japanese Patients" @default.
• W3036005157 cites W1493420262 @default.
• W3036005157 cites W1890529144 @default.
• W3036005157 cites W1972202505 @default.
• W3036005157 cites W1979189074 @default.
• W3036005157 cites W1987600922 @default.
• W3036005157 cites W1991267023 @default.
• W3036005157 cites W2005004579 @default.
• W3036005157 cites W2007469043 @default.
• W3036005157 cites W2031400172 @default.
• W3036005157 cites W2034790296 @default.
• W3036005157 cites W2035635857 @default.
• W3036005157 cites W2039959808 @default.
• W3036005157 cites W2046528911 @default.
• W3036005157 cites W2049997278 @default.
• W3036005157 cites W2060016825 @default.
• W3036005157 cites W2080747866 @default.
• W3036005157 cites W2082019351 @default.
• W3036005157 cites W2083622314 @default.
• W3036005157 cites W2089892642 @default.
• W3036005157 cites W2090636148 @default.
• W3036005157 cites W2096500160 @default.
• W3036005157 cites W2099937170 @default.
• W3036005157 cites W2102804688 @default.
• W3036005157 cites W2136904160 @default.
• W3036005157 cites W2163140311 @default.
• W3036005157 cites W2324787434 @default.
• W3036005157 cites W2329573625 @default.
• W3036005157 cites W2470325703 @default.
• W3036005157 cites W2513577748 @default.
• W3036005157 cites W2592085898 @default.
• W3036005157 cites W2810071785 @default.
• W3036005157 cites W2896847315 @default.
• W3036005157 cites W2919372986 @default.
• W3036005157 cites W2939258110 @default.
• W3036005157 cites W2942673049 @default.
• W3036005157 cites W2946423642 @default.
• W3036005157 cites W2999797317 @default.
• W3036005157 cites W3007141035 @default.
• W3036005157 cites W3012080550 @default.
• W3036005157 cites W3013675935 @default.
• W3036005157 cites W4241551895 @default.
• W3036005157 doi "https://doi.org/10.3390/ijms21124347" @default.
• W3036005157 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7352351" @default.
• W3036005157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32570960" @default.
• W3036005157 hasPublicationYear "2020" @default.
• W3036005157 type Work @default.
• W3036005157 sameAs 3036005157 @default.
• W3036005157 citedByCount "4" @default.
• W3036005157 countsByYear W30360051572021 @default.
• W3036005157 countsByYear W30360051572022 @default.
• W3036005157 countsByYear W30360051572023 @default.
• W3036005157 crossrefType "journal-article" @default.
• W3036005157 hasAuthorship W3036005157A5002391399 @default.
• W3036005157 hasAuthorship W3036005157A5004410085 @default.
• W3036005157 hasAuthorship W3036005157A5051804635 @default.
• W3036005157 hasAuthorship W3036005157A5067289515 @default.
• W3036005157 hasAuthorship W3036005157A5070223885 @default.
• W3036005157 hasBestOaLocation W30360051571 @default.
• W3036005157 hasConcept C104317684 @default.
• W3036005157 hasConcept C109650736 @default.
• W3036005157 hasConcept C126322002 @default.
• W3036005157 hasConcept C135763542 @default.
• W3036005157 hasConcept C19831878 @default.
• W3036005157 hasConcept C203014093 @default.
• W3036005157 hasConcept C2779134260 @default.
• W3036005157 hasConcept C2780035454 @default.
• W3036005157 hasConcept C2780479503 @default.
• W3036005157 hasConcept C2909675724 @default.
• W3036005157 hasConcept C2911091166 @default.
• W3036005157 hasConcept C526171541 @default.
• W3036005157 hasConcept C54355233 @default.
• W3036005157 hasConcept C62231903 @default.
• W3036005157 hasConcept C71924100 @default.
• W3036005157 hasConcept C86803240 @default.
• W3036005157 hasConcept C90924648 @default.
• W3036005157 hasConcept C92137452 @default.
• W3036005157 hasConcept C98274493 @default.
• W3036005157 hasConceptScore W3036005157C104317684 @default.
• W3036005157 hasConceptScore W3036005157C109650736 @default.
• W3036005157 hasConceptScore W3036005157C126322002 @default.
• W3036005157 hasConceptScore W3036005157C135763542 @default.
• W3036005157 hasConceptScore W3036005157C19831878 @default.
• W3036005157 hasConceptScore W3036005157C203014093 @default.
• W3036005157 hasConceptScore W3036005157C2779134260 @default.
• W3036005157 hasConceptScore W3036005157C2780035454 @default.
• W3036005157 hasConceptScore W3036005157C2780479503 @default.
• W3036005157 hasConceptScore W3036005157C2909675724 @default.
• W3036005157 hasConceptScore W3036005157C2911091166 @default.

• next